학술논문
A phase 3, randomized, open-label study of nivolumab combined with cabozantinib vs sunitinib in patients with previously untreated advanced or metastatic renal cell carcinoma (RCC; CheckMate 9ER).
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755